| 000 | 00906nam a22002777a 4500 | ||
|---|---|---|---|
| 008 | 180305b xxu||||| |||| 00| 0 eng d | ||
| 040 | _cVAD | ||
| 041 | _aEngels | ||
| 110 | _aSubstance Abuse Mental Health Services Administration [SAMHSA] | ||
| 245 | _aMedications for opioid use disorder : for healthcare and addiction professionals, policymakers, patients, and families [PDF] | ||
| 260 |
_aS.l. _bSAMHSA _c2018 |
||
| 300 | _a306 p. | ||
| 490 |
_aTreatment Improvement Protocol (TIP) _v63 |
||
| 650 | _adrugs | ||
| 650 | _aopiaten | ||
| 650 | _aheroïne | ||
| 650 | _ahulpverlening | ||
| 650 | _afarmacotherapie | ||
| 650 | _amethadon | ||
| 650 | _abuprenorfine | ||
| 650 | _analoxon | ||
| 650 | _abehandelrichtlijnen | ||
| 650 | _arichtlijnen | ||
| 650 | _aVS | ||
| 856 | _uhttp://www.google.com/search?q=Medications-for-opioid-use-disorder for-healthcare-and-addiction-professionals | ||
| 999 |
_c19531 _d19531 |
||